RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 47 filers reported holding RAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,551 | -48.5% | 91,148 | -28.2% | 0.00% | – |
| Q2 2023 | $152,392 | -36.8% | 126,993 | +360.3% | 0.00% | – |
| Q1 2023 | $241,154 | +105.1% | 27,592 | +87.8% | 0.00% | – |
| Q4 2022 | $117,568 | +80.9% | 14,696 | +10.4% | 0.00% | – |
| Q3 2022 | $65,000 | -18.8% | 13,315 | -8.4% | 0.00% | – |
| Q2 2022 | $80,000 | -87.1% | 14,530 | -88.1% | 0.00% | – |
| Q1 2022 | $618,000 | -33.5% | 121,824 | +69.0% | 0.00% | – |
| Q4 2021 | $929,000 | -10.9% | 72,097 | +3.4% | 0.00% | – |
| Q3 2021 | $1,043,000 | -12.0% | 69,693 | -8.6% | 0.00% | – |
| Q2 2021 | $1,185,000 | – | 76,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $8,677,000 | 2.31% |
| Cormorant Asset Management, LP | 2,326,660 | $12,936,000 | 0.98% |
| BVF INC/IL | 3,526,729 | $19,609,000 | 0.95% |
| Perceptive Advisors | 2,483,619 | $13,809,000 | 0.43% |
| Boxer Capital, LLC | 1,175,000 | $6,533,000 | 0.41% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 333,251 | $1,853,000,000 | 0.03% |
| Laurion Capital Management LP | 313,200 | $1,741,000 | 0.03% |
| Lumina Fund Management LLC | 6,000 | $33,000 | 0.01% |
| Ergoteles LLC | 70,700 | $393,000 | 0.01% |
| Woodline Partners LP | 119,700 | $666,000 | 0.01% |